The untranslated roX1 and roX2 RNAs are components of the Drosophila male-specific lethal (MSL) complex, which modifies histones to up-regulate transcription of the male X chromosome. roX genes are normally located on the X chromosome, and roX transgenes can misdirect the dosage compensation machinery to spread locally on other chromosomes. Here we define MSL protein abundance as a determinant of whether the MSL complex will spread in cis from an autosomal roX transgene. The number of expressed roX genes in a nucleus was inversely correlated with spreading from roX transgenes. We suggest a model in which MSL proteins assemble into active complexes by binding nascent roX transcripts. When MSL protein/roX RNA ratios are high, assembly will be efficient, and complexes may be completed while still tethered to the DNA template. We propose that this local production of MSL complexes determines the extent of spreading into flanking chromatin.
The untranslated roX1 and roX2 RNAs are components of the Drosophila male-specific lethal (MSL) complex, which modifies histones to up-regulate transcription of the male X chromosome. roX genes are normally located on the X chromosome, and roX transgenes can misdirect the dosage compensation machinery to spread locally on other chromosomes. Here we define MSL protein abundance as a determinant of whether the MSL complex will spread in cis from an autosomal roX transgene. The number of expressed roX genes in a nucleus was inversely correlated with spreading from roX transgenes. We suggest a model in which MSL proteins assemble into active complexes by binding nascent roX transcripts. When MSL protein/roX RNA ratios are high, assembly will be efficient, and complexes may be completed while still tethered to the DNA template. We propose that this local production of MSL complexes determines the extent of spreading into flanking chromatin.
A key mechanism for regulating eukaryotic gene expression is alteration of DNA packaging into chromatin (1) . Modified chromatin architecture can sometimes be propagated long distances in cis from an initiation point (2) (3) (4) (5) (6) , but the mechanism of such spreading is not understood. The MSL dosage compensation complex is thought to spread along the single male X chromosome in Drosophila (7) . The MSL complex is composed of at least six proteins and two noncoding roX RNAs that paint the male X chromosome, leading to covalent modification of the NH 2 -terminal tails of histones H3 and H4 and twofold hypertranscription of hundreds of linked genes (8) (9) (10) .
The two roX RNAs perform redundant functions (11, 12) . The lethality of roX1 roX2 double-mutant males can be rescued by expression of either roX1 or roX2 RNA from autosomal locations, showing that roX RNAs can be supplied in trans to coat the X chromosome (12) . However, both genes synthesizing roX RNAs are normally located on the X chromosome, and we have suggested that this contributes to targeting dosage compensation to the correct chromosome (7) .
In certain msl mutant backgrounds, the MSL complex is absent from most locations on the X chromosome, but a small subset of sites, termed chromatin entry sites, retain partial complexes (7, 13) . Two of these sites are the roX genes. When a roX gene is moved to an autosome, it recruits MSL complex, which occasionally spreads up to 1 megabase (Mb) into the flanking autosome in a pattern that varies considerably (Fig. 1A) . This suggested that the MSL complex recognizes the X chromosome by first binding at roX genes (and perhaps additional sites) and then spreading in cis (7) . The MSL proteins could recognize the roX genes by binding DNA, nascent RNA, or both. MSL proteins bind roX RNAs to form active complexes, and each roX gene also contains an MSL binding site (9, 14) .
The ectopic MSL spreading observed from autosomal roX transgenes was seen in only a small fraction of nuclei compared with the invariant MSL pattern in the wildtype male X chromosome (7, 13) . During complementation analyses of roX1 roX2 mutants, we unexpectedly found that the genotype of the X chromosome strongly influenced ectopic MSL spreading from autosomal transgenes. We observed essentially no spreading in the presence of a wild-type X chromosome, but mutations in either roX1 or roX2 separately allowed modest MSL spreading from autosomal roX transgenes in some nuclei ( Table 1 ; Fig. 1 , B to D). In contrast, roX1 roX2 mutants displayed extensive autosomal MSL spreading [Ͼ1 megabase pair (Mbp)] in nearly all nuclei regardless of their insertion site (Fig. 1, E to I; Fig. 2, A and B) , including centric heterochromatin (Fig. 1I) . In each case, MSL complexes still painted the X chromosome. Autosomal roX transgenes were poor sites of MSL spreading if one or both endogenous roX genes were functioning on the X chromosome, but the same transgenes supported efficient MSL spreading over autosomes in a roX1 roX2 double mutant. Thus, roX genes appear to compete for limiting components for chromatin spreading.
We next asked if only X-linked roX genes could compete with autosomal MSL spreading. We found that a second autosomal roX transgene strongly reduced spreading from a reference roX transgene. For example, the MSL complex spread several megabase pairs from P{w ϩ GMroX2}97F (henceforth transgenics will be referred to as GMroX1-location or GMroX2-location, i.e., GMroX2-97F) in nearly all nuclei when it was the only source of roX RNA ( Table 1 ; Fig. 2B ). However, spreading was greatly reduced when GMroX1-67B was also present ( Fig. 2C ; Table 1 ). We tested seven pairs of roX transgenes and found that spreading from one site was reduced in both frequency and extent by the presence of a second roX gene ( Table 1 ) (15) . This confirms that the factors on the wild-type X chromosome responsible for competing for MSL spreading from an autosomal transgene are the endogenous roX genes and shows that roX genes are potent inhibitors of ectopic MSL spreading regardless of location.
The ability to compete with ectopic MSL spreading might reside in the roX RNAs or in the MSL binding sites within the roX genes. We constructed stocks in which MSL cis spreading from a reference GMroX2-97F transgene was challenged with two different roX1 cDNA transgenes, both of which contain an MSL binding site. In one case, the roX1 cDNA was transcribed from the constitutive Hsp83 promoter (13) . This transgene strongly competed with MSL spreading from GMroX2-97F (Table 2 ). The other roX1 cDNA transgene lacked a promoter and produced no detectable RNA (Fig. 2D , lane 9) (14) . The nontranscribed cDNA failed to compete for MSL spreading from GMroX2-97F (Table 2) . Thus, the active factor competing for ectopic autosomal MSL spreading is the roX RNA product. The MSL binding site within roX1 clearly is not sufficient and may play no role.
One possible explanation for our results is that roX transcripts compete to assemble MSL proteins into functional complexes. Because roX RNAs are unstable unless bound by MSL proteins (13, 15) , steady-state levels of one roX RNA species might fall if another roX species captured most MSL proteins. We measured the steady-state level of roX2 RNA made by GMroX2 when it was the only source of roX RNA or when roX1 RNA was also made from the endogenous gene on the (1)roX2 52 (12) , is on the X chromosome at 18F (15). X chromosome or an autosomal transgene. When the GMroX2-97F or the GMroX2-85B transgene was the only source of roX RNA and complexes spread efficiently in cis, we observed high levels of roX2 RNA (Fig. 2D , lanes 5 and 7). When roX1 RNA was also present, MSL spreading was greatly inhibited around the GMroX2 transgenes and the amount of roX2 RNA fell. It made no difference if the roX1 RNA came from the endogenous locus on the X chromosome (Fig. 2D,  lane 4) , the GMroX1 autosomal transgene (Fig. 2D, lane 6) , or the H83roX1 transgene (Fig. 2D, lane 8) .
Competition between endogenous roX genes and autosomal roX transgenes
Transcription at GMroX2 might be indirectly repressed by the presence of roX1 RNA through feedback regulation. Alternatively, similar amounts of roX2 RNA may be made in all cases, but, when roX1 RNA competes for MSL proteins, roX2 transcripts may be inefficiently packaged into complexes and the naked RNAs then degraded. We reexamined ectopic MSL spreading from eight roX transgenes under conditions in which both MSL1 and MSL2 were overexpressed from constitutive promoters (16) . GMroX1-67B and GMroX2-97F are typical examples that show dramatic spreading in the absence of any other roX genes (Fig. 2, A and B) but rare spreading when the X chromosome carried a functional roX1 or roX2 gene (Fig. 2, E and G) . This competition between roX genes was partially overcome when MSL1 and MSL2 proteins were overexpressed, as spreading from either transgene was clearly increased in both frequency and extent, despite the presence of a functioning roX gene on the X chromosome (Fig. 2, F and H) (15) . These results strongly suggest that MSL proteins are normally recruited by roX RNAs to begin the spreading process and that the local concentration of MSL complexes at a roX gene determines the extent of epigenetic spreading into flanking chromatin.
Although the MSL complex has been reported to up-regulate transcription of flanking genes by histone modification (17, 18) , this model for dosage compensation in Drosophila has been disputed (19) . The ability to cause consistent MSL spreading on autosomes provides an opportunity to examine the direct effect of MSL complexes on the transcription status of individual flanking genes. We used a GMroX1 transgene inserted at position 69C, where the linked reporter gene mini-white is expressed only in the dorsal part of the eye (Fig. 3, A and B) (20) . GMroX1-69C flies showed a striking sex difference in eye pigmentation superimposed on this dorsoventral pattern. Males displayed sporadic red sectors of mini-white expression ventrally, suggesting that the roX gene recruited the MSL complex to partially overcome the local repressive chromatin environment. When the X chromosome carried a roX ϩ gene, derepression of mini-white was a rare event, resulting in a few pigmented sectors, but in a roX1 roX2 mutant background, mini-white expression in the ventral half of the eye was almost totally derepressed in males (Fig. 3, D versus B and C) . As a control, we tested another nearby mini-white transgene, P{lacW}mirr B1-12 , lacking any roX sequences (21) , and it was not affected by roX mutations (Fig. 3, E and F) . These results suggest that spreading is likely to be a general phenomenon, occurring in many or most tissues of the animal. When the MSL complex spreads over genes surrounding roX1, the chromatin is remodeled for increased transcription. If ectopic MSL spreading occurs in a repressive chromatin environment, even strong silencing may be overcome. The consistency of ectopic spreading correlates with increased transcription of flanking chromatin.
We have found conditions in which roX RNAs either assemble into MSL complexes that preferentially spread in cis from the site of transcription or diffuse to the X chromosome. We propose that these outcomes are determined by MSL proteins assembling onto growing roX transcripts tethered to the chromosome. The local pool of MSL proteins would control the efficiency of this process. If active complexes are completed by the time 3Ј RNA processing releases the RNA from the chromosome, the most likely outcome is immediate entry and spreading into flanking chromatin. If the supply of MSL subunits is reduced by a competing source of roX RNA, release of roX transcripts might precede complex maturation. These MSL complexes are unlikely to return to the transgene after assembly in solution and instead diffuse to the X chromosome, which, in addition to roX genes, has unknown features that make it the best target for MSL complexes.
